Percutaneous closure of a patent foramen ovale (PFO), a common variation of interatrial
septum anatomy, is a commonly performed procedure in the catheterization laboratory to …

Patent Foramen Ovale (PFO) is a common congenital atrial septal defect present in 20%–
35% of the general population. Although generally considered a benign anatomic variant, a …

Mechanisms of ineffective patent foramen ovale closure using the percutaneous suture-mediated
NobleStitch system - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Objectives Transcatheter closure has become one of the main treatment methods for patent
foramen ovale (PFO). However, the population in southern China is generally thin and the …

Background NobleStitch EL is a novel suture‐based technique used for patent foramen
ovale (PFO) closure and an alternative to traditional double‐disc devices without the need …

Background Percutaneous suture-mediated patent foramen ovale (PFO) closure has
recently been used with the aim of avoiding double-disc nitinol device implantation. This …

Aims Suture-mediated patent fossa ovalis (PFO) closure is a recent technique, achieving
closure by means of a simple suture. The differences between traditional occluders and …

Objectives To identify a simple echocardiographic predictor of procedural success to select
patient for percutaneous suture‐mediated patent fossa ovalis (PFO) closure. Background …

Methods Between July 2017 and July 2020, 80 consecutive patients underwent
percutaneous suture-mediated PFO closure with the NobleStitch EL device (HeartStitch) at …

Discussion Recent clinical trials have indicated that patients with cryptogenic stroke
experience better outcomes and have a reduced risk of recurrent cryptogenic stroke when …